Trial Outcomes & Findings for Acceptance & Tolerance Study of Multifocal Contact Lenses by Functional Emmetropes (NCT NCT02394925)

NCT ID: NCT02394925

Last Updated: 2018-06-19

Results Overview

Proportion of Successful contact lens wearers is based on a subject's responses to two questionnaire items, "Overall Quality of Vision" and "Overall Comfort". Each item uses a 6 response like-rt scale (0= Not Applicable, 1=Excellent, 2=Very Good, 3=Good, 4=Fair and 5=Poor). The data from each item was dichotomized into two groups. If a subject responded "Excellent", "Very Good" or "Good" then the response=1, otherwise the response=0. The proportion of subjects with response=1 was reported as the proportion of successful contact lens wearers.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

113 participants

Primary outcome timeframe

2 months post wear

Results posted on

2018-06-19

Participant Flow

A total of 113 enrolled into this study. Of the enrolled, 5 subjects did not meet the eligibility criteria and 108 subjects were dispensed the study lens. Of the dispensed subjects 79 completed the study while 29 subjects were discontinued.

Participant milestones

Participant milestones
Measure
Etafilcon -PVP (Multi-focal)
All subjects in the study wore the test lens etafilcon- PVP (Multi-focal) throughout the entire duration of the study.
Overall Study
STARTED
108
Overall Study
COMPLETED
79
Overall Study
NOT COMPLETED
29

Reasons for withdrawal

Reasons for withdrawal
Measure
Etafilcon -PVP (Multi-focal)
All subjects in the study wore the test lens etafilcon- PVP (Multi-focal) throughout the entire duration of the study.
Overall Study
Adverse Event
1
Overall Study
Lens Discomfort
3
Overall Study
Lens handling difficulities
5
Overall Study
Lost to Follow-up
9
Overall Study
Protocol Violation
5
Overall Study
No longer meet eligibility criteria
1
Overall Study
Unsatisfactory Visual Response
5

Baseline Characteristics

Acceptance & Tolerance Study of Multifocal Contact Lenses by Functional Emmetropes

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Dispensed Subjects
n=108 Participants
All subjects in that were dispensed the study lens.
Age, Continuous
49.9 years
STANDARD_DEVIATION 6.13 • n=5 Participants
Sex: Female, Male
Female
61 Participants
n=5 Participants
Sex: Female, Male
Male
47 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
1 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
31 Participants
n=5 Participants
Race (NIH/OMB)
White
73 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants
n=5 Participants
Region of Enrollment
United States
46 participants
n=5 Participants
Region of Enrollment
United Kingdom
62 participants
n=5 Participants

PRIMARY outcome

Timeframe: 2 months post wear

Population: Subjects that completed all study visits without a major protocol deviation.

Proportion of Successful contact lens wearers is based on a subject's responses to two questionnaire items, "Overall Quality of Vision" and "Overall Comfort". Each item uses a 6 response like-rt scale (0= Not Applicable, 1=Excellent, 2=Very Good, 3=Good, 4=Fair and 5=Poor). The data from each item was dichotomized into two groups. If a subject responded "Excellent", "Very Good" or "Good" then the response=1, otherwise the response=0. The proportion of subjects with response=1 was reported as the proportion of successful contact lens wearers.

Outcome measures

Outcome measures
Measure
Etafilcon -PVP (Multi-focal)
n=78 Participants
All subjects in the study wore the test lens etafilcon- PVP (Multi-focal) throughout the entire duration of the study.
Proportion of Successful Contact Lens Wearers
0.71 Proportion of Subjects

Adverse Events

Etafilcon -PVP (Multi-focal)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Thomas R. Karkkainen, OD, MS, FAAO Sr. Principal Research Optometrist

Johnson & Johnson Vision Care Inc.

Phone: 904 443-3402

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: GT60